middle.news
Race Oncology Expands RC220 Trial to Hong Kong with Ethics Approvals
9:19am on Thursday 10th of July, 2025 AEST
•
Healthcare
Read Story
Race Oncology Expands RC220 Trial to Hong Kong with Ethics Approvals
9:19am on Thursday 10th of July, 2025 AEST
Key Points
Human Research Ethics Committee approvals granted for Prince of Wales and Queen Mary Hospitals
Trial to assess safety and pharmacokinetics of RC220 combined with doxorubicin in solid tumour patients
Pending final Department of Health approval and site activations for patient enrolment
Expansion aims to gather clinical data in East Asian populations and speed recruitment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE